Use of TOMI SteraMist Technology for Hurricane Sandy Clean-up

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--TOMI Environmental Solutions, Inc. (“TOMI”) (OTCBB:TOMZ), a global bacteria decontamination and infectious disease control company, announced that its SteraMist activated hydrogen peroxide technology has been utilized in clean-up efforts in connection with Hurricane Sandy.

“SteraMist deactivates organic compounds and quickly and effectively kills viruses, bacteria, spores, mold, and fungi in the air and on surfaces. This fast-acting biological disinfection leaves no residue or noxious fumes and is environmentally friendly.”

Within hours following Hurricane Sandy flooding communities across several mid-Atlantic and Northeastern states, and with particularly severe damage to the coastline of New Jersey and New York, Rolyn, a nationwide property disaster recovery and restoration services company and a TOMI alliance partner, deployed equipment, manpower and Emergency Response Command Centers to various locations in New York, New Jersey, and the Washington Metropolitan area.

Rolyn’s indoor air remediation and sterilization services utilized TOMI’s SteraMist product in New York and New Jersey to decontaminate black water situations as a result of the flooding. In addition, Rolyn is also servicing other commercial, multi-family, healthcare, and countless residential clients to help restore damage efficiently and quickly. Rolyn relies on start-of-the-art technology to offer their clients the best solutions available. SteraMist technology was developed by L-3 Communications (NYSE:LLL). When describing the SteraMist product, the Rolyn website reports, “SteraMist deactivates organic compounds and quickly and effectively kills viruses, bacteria, spores, mold, and fungi in the air and on surfaces. This fast-acting biological disinfection leaves no residue or noxious fumes and is environmentally friendly.”

About TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. (OTCBB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing green energy-efficient environmental solutions for indoor surface decontamination through sales and licensing of our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone Generators and Ultra-Violet Germicidal Irradiation (“UVGI”) products and technologies.

TOMI’s products are designed to service a broad spectrum of commercial structures including medical facilities, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with the Indoor Air Quality Association, The International Ozone Association and The United States Green Building Council.

For additional product information, visit TOMI’s website at www.tomiesinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.